SPACRCAN Inhibitors
Chemical inhibitors of SPACRCAN can exert their inhibitory effects through a variety of mechanisms by targeting specific signaling pathways and enzymes that regulate the activity of this protein. Staurosporine, a broad-spectrum kinase inhibitor, can suppress the activity of multiple kinases that may serve as upstream regulators or direct activators of SPACRCAN, thereby leading to its functional inhibition. Similarly, Wortmannin and LY294002, both inhibitors of PI3K, can disrupt PI3K-dependent pathways that may be crucial for SPACRCAN's regulation, effectively inhibiting its function. Rapamycin, which targets mTOR signaling, can also inhibit SPACRCAN by preventing the activation of downstream pathways that SPACRCAN may rely on for its function.
Continuing with the theme of targeted pathway inhibition, PP2 can selectively inhibit Src family tyrosine kinases potentially involved in the regulation of SPACRCAN, leading to an inhibition of its activation and function. SB203580, through its specific inhibition of p38 MAPK, and U0126 and PD98059, both targeting MEK1/2 upstream of ERK in the MAPK pathway, can each disrupt the signaling pathways that may control the activity of SPACRCAN, thereby inhibiting its function. SP600125's inhibition of JNK signaling can also lead to functional inhibition of SPACRCAN if JNK signaling is part of SPACRCAN's regulatory network. KN-93's selective inhibition of CaMKII can suppress the activity of SPACRCAN if CaMKII is involved in the protein's regulatory cascade. Lastly, Bortezomib and MG132, as proteasome inhibitors, can prevent the ubiquitin-proteasome-mediated regulation of proteins that modulate SPACRCAN's activity, leading to the inhibition of SPACRCAN through stabilization of its regulatory factors.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor that can inhibit a broad spectrum of kinases which may be upstream regulators or direct activators of SPACRCAN protein, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, and if SPACRCAN is regulated by PI3K signaling, this compound would inhibit the activation of downstream signals necessary for SPACRCAN function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor, which can inhibit the PI3K-dependent pathways that may be involved in the regulation of SPACRCAN, thus inhibiting its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, and if SPACRCAN activity is linked with mTOR signaling pathways, inhibition of mTOR by Rapamycin would result in the functional inhibition of SPACRCAN. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases which could be involved in activating pathways that regulate SPACRCAN, thus PP2 would functionally inhibit SPACRCAN by inhibiting its activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAPK, and if SPACRCAN activity requires p38 MAPK signaling, inhibition by SB203580 would disrupt SPACRCAN's function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which are upstream of ERK in the MAPK pathway, and if SPACRCAN function depends on this pathway, U0126 would inhibit SPACRCAN activity by this mechanism. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor which would inhibit the activation of ERK, potentially preventing the phosphorylation and activation of proteins that regulate SPACRCAN, leading to its functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, and if the activity of SPACRCAN is regulated by JNK signaling, its inhibition by SP600125 would result in functional inhibition of SPACRCAN. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of CaMKII, and if CaMKII is part of the signaling cascade that regulates SPACRCAN, inhibition by KN-93 would suppress SPACRCAN activity. | ||||||